Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.9604
-0.0496 (-4.91%)
At close: Aug 20, 2026, 4:00 PM EDT
0.9991
+0.0387 (4.03%)
After-hours: Aug 20, 2026, 5:48 PM EDT

Lucid Diagnostics Revenue

Lucid Diagnostics had revenue of $1.47M in the quarter ending June 30, 2026, with 26.74% growth. This brings the company's revenue in the last twelve months to $5.45M, up 24.89% year-over-year. In the year 2025, Lucid Diagnostics had annual revenue of $4.71M with 8.28% growth.

Revenue (ttm)
$5.45M
Revenue Growth
+24.89%
P/S Ratio
33.71
Revenue / Employee
$66,402
Employees
82
Market Cap
183.39M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20254.71M360.00K8.28%
Dec 31, 20244.35M1.92M79.00%
Dec 31, 20232.43M2.05M544.03%
Dec 31, 2022377.00K-123.00K-24.60%
Dec 31, 2021500.00K--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Inogen354.30M
Neuronetics155.10M
Quanterix153.41M
InfuSystem Holdings143.34M
RxSight127.58M
Owlet114.41M
Standard BioTools84.60M
Apyx Medical58.42M
Revenue Rankings